CarbGeM Inc. is a Japan-based startup dedicated to combating antibiotic-resistant bacteria with their next-generation medical device. Their flagship product, BiTTE, is an application designed to estimate bacterial species in bacterial infections and provide support in selecting appropriate antibiotics. Utilizing AI image recognition technology for Gram stain images, BiTTE ensures highly accurate bacterial species estimation and guides the selection of antibiotics by connecting with antibiograms. In addition to this cutting-edge application, CarbGeM Inc. offers Point of Care Gram Staining (PoCGS), a small and affordable medical device designed for installation in emergency outpatient departments, intensive care units, and community clinics. PoCGS allows for quick staining of patient samples on a slide glass, with the stained samples being completed in just 10 minutes. The device's operation panel enables the adjustment of sample types, reagent titration amount, staining time, and other relevant parameters. Founded in 2021, CarbGeM Inc. operates within the AI, Biopharma, Health Care, and Medical Devices industries. As for their current funding status, there is no public information available regarding last investment or investors. This innovative startup is poised to make meaningful contributions in the fight against antibiotic resistance and the improvement of healthcare outcomes.
There is no investment information
No recent news or press coverage available for CarbGeM Inc..